Resources Guerdjikova, A., Mori, N., Casuto, L.S., & McElroy, S.L
These offerings are built on a platform that is engineered to care through predictive engagement of population health needs, proactive care that improves outcomes and cost savings, and by addressing barriers to access and continuity of care
Test subjects were included in the study if they were at least 18 years of age with a type 2 diabetes diagnosis and stable treatment with metformin, thiazolidinediones, and/or sulfonylureas, for at least 90 days prior to the initiation of the experiment
Weight loss faster than 2 pounds per week raises risk for gallstones, muscle loss, and hair shedding
Glucagon-like peptide-1 ( GLP-1 ) receptor agonists, such as semaglutide (Wegovy) or tirzepatide (Zepbound), reduce hunger and cravings, making it easier to maintain a calorie deficit during plateaus
Editorial: the changing faces of glutathione, a cellular protagonist